Nemolizumab Clinical Trials: Promising Results for Eczema and Prurigo Nodularis
Nemolizumab Clinical Trials: Promising Results for Eczema and Prurigo Nodularis Nemolizumab, a monoclonal antibody that targets the interleukin-31 receptor A, has shown […]